You are here: Industry Insights > cancer

News List

Rural Residents More Fatalistic About Cancer drugs.com
February 09, 2022
Rural residents show higher levels of cancer fatalism and cancer information overload than urban residents, according to a study published ...
cancer patients miss out on innovative new treatments pharmatimes
February 07, 2022
Institute for Cancer Research highlights missed opportunity for NICE to reform its cancer drug assessment processes.
Sajid Javid combats cancer crisis pharmatimes
February 04, 2022
UK’s health and social care secretary will declare war on cancer with a decade-long plan to combat disease misery.
FLIP sync: Collaboration for inhibitors and cancer treatments pharmatimes
January 26, 2022
Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments.
Know Your Thyroid Facts drugs
January 10, 2022
Thyroid cancer diagnoses have spiked for U.S. women this past decade.
Protecting People with Cancer from COVID-19: New Recommendations from Cancer Guidelines Organization prnewswire
January 05, 2022
Today, the National Comprehensive Cancer Network® (NCCN®) published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of COVID-19 in people with cancer.
New blood test can identify presence of cancer pharmatimes
January 05, 2022
The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.
Five-drug combination for ultra-high-risk bone marrow cancer identified PharmaTimes
December 14, 2021
A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.
50 Years of Progress in Treating Patients with Cancer FDA
December 13, 2021
By Richard Pazdur, MD, Director, Oncology Center of Excellence (OCE) and Acting Director, Office of Oncologic Diseases (OOD)
LianBio Provides Corporate Update and Reports Third Quarter 2021 Financial Results PhamaSources.com
December 10, 2021
LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page